|
BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer |
|
|
|
Titel: |
BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer |
Auteur: |
Epaillard, Nicolas Simonaggio, Audrey Elaidi, Reza Azzouz, Fouzia Braychenko, Elena Thibault, Constance Sun, Cheng-Ming Moreira, Marco Oudard, Stéphane Vano, Yann-Alexandre |
Verschenen in: |
Bulletin du cancer |
Paginering: |
Jaargang 107 () nr. 5S pagina's eS22-eS27 |
Jaar: |
2020 |
Inhoud: |
|
Uitgever: |
Elsevier Masson SAS |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|